SOX4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64212000000052E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.30240000000026E-05 |
Normal-vs-Stage2 |
2.14199999999387E-05 |
Normal-vs-Stage3 |
1.19590000002834E-06 |
Normal-vs-Stage4 |
1.391120E-04 |
Stage1-vs-Stage2 |
3.053400E-01 |
Stage1-vs-Stage3 |
5.356300E-02 |
Stage1-vs-Stage4 |
9.513400E-01 |
Stage2-vs-Stage3 |
8.769000E-01 |
Stage2-vs-Stage4 |
4.277000E-01 |
Stage3-vs-Stage4 |
2.218200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.34999999995755E-06 |
Normal-vs-AfricanAmerican |
9.240500E-03 |
Normal-vs-Asian |
4.338200E-01 |
Caucasian-vs-AfricanAmerican |
1.488170E-01 |
Caucasian-vs-Asian |
9.492300E-02 |
AfricanAmerican-vs-Asian |
6.253200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.15689999999435E-05 |
Normal-vs-Female |
4.31929999999969E-06 |
Male-vs-Female |
3.603000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.452300E-02 |
Normal-vs-Age(41-60Yrs) |
7.60360000000571E-05 |
Normal-vs-Age(61-80Yrs) |
2.89610000003826E-06 |
Normal-vs-Age(81-100Yrs) |
2.07560002518647E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.941400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.202430E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.057060E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.189410E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.66640000000196E-05 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.398200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.246200E-02 |
Normal-vs-Grade 2 |
8.21410000000355E-05 |
Normal-vs-Grade 3 |
3.11480000003694E-06 |
Normal-vs-Grade 4 |
2.80600000002185E-06 |
Grade 1-vs-Grade 2 |
4.479600E-01 |
Grade 1-vs-Grade 3 |
1.664640E-01 |
Grade 1-vs-Grade 4 |
8.458300E-02 |
Grade 2-vs-Grade 3 |
1.085830E-01 |
Grade 2-vs-Grade 4 |
9.362000E-02 |
Grade 3-vs-Grade 4 |
7.589200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.8958999999722E-07 |
Normal-vs-ccB subtype |
2.047700E-04 |
ccA subtype-vs-ccB subtype |
1.428060E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.53869999999223E-05 |
Normal-vs-N1 |
1.79673999999297E-05 |
N0-vs-N1 |
3.773200E-01 |
|
|